Travoprost represents the first ophthalmic solution in Sagent's growing product portfolio SCHAUMBURG, Ill., Sept. 15, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, today announced its entry into the ophthalmic market and...
Sagent Announces Launch of Travoprost Ophthalmic Solution, USP
Seeking Alpha / 5 hours ago 1 Views
Comments